Coherus BioSciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Events That Accelerate or Increase a Direct Financial Obligation, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits